Key Takeaways
- Record quarter, defense-led: Revenue hit ₹299 cr (+22.7% QoQ, +13% YoY) and EBITDA an all-time high of ₹47 cr (15.7% margin), driven by defense growing 37% YoY.
- Power930 ambition launched: The company set a ₹9,000 crore revenue target by 2030, backed by three new manufacturing facilities and a 70% growth trajectory from FY28 onward.
- Defense margins are capped at 22%: Management called 22% “pretty high” and said they would be “lucky to maintain that for next four years,” with OEM work the only lever for improvement.
- ESAI is in a deliberate trough: The segment slowed as the company pivots from design-only to manufacturing; the EMS facility comes online by March ‘26, with hyperscaler revenue expected to jump from $2 mn to $6–7 mn next year.
- What to watch next quarter: Whether the BrahMos seeker trial succeeds by March (unlocking ESA orders), the TACAN antenna production order lands within a month, and the strategic advisor’s portfolio review delivers a concrete divestment path.
The Power930 Bet: Facilities, Funding & the 70% Jump
The company’s headline ambition is to reach ₹9,000 crores (~\$1 bn) by 2030. The math: 45% growth in FY26 and FY27, then 70% annually in FY28, FY29, and FY30, with the acceleration coming entirely from new manufacturing facilities.
- Three facilities, three phases: The Devanahalli Aeroland facility (165,000 sq ft for electronics, semiconductors, AI, and test systems) is already partly operational. The Devanahalli Atmanirbhar Complex (radar, unmanned warfare, offset fulfillment) broke ground; Phase I (radar manufacturing, assembly, antenna) targets completion by September next year, Phase II (aerospace field shops, supply chain) by December next year. A missile Atmanirbhar Complex in Hyderabad was sanctioned the day before the call.
- CAPEX plan: ~₹150 cr for Phase I, ~₹450 cr for Phase II, with the remainder of ~₹1,500 cr spread over three years including Hyderabad.
- Funding strategy is staged, not committed: Phase I is funded through internal accruals. Management wants to build a “scalable model” with Phase I so investors “can see and believe,” then take strategic investment, likely in Q1 of next year. No equity dilution is planned in the listed entity; strategic investment would go into an SPV holding the Bangalore land. The company does not want debt beyond bridge financing, but declined to name a maximum debt level.
Dr. S. Ravinarayanan: “We are trying to create a scalable model, with this Rs.150 crores the phase-I will create a scalable model so that people can see and believe. Then we want to take that investment. So, probably, we will do it in the Q1 of next year.”
Defense: The Growth Engine, With a Margin Ceiling
Defense revenues grew 37% YoY in Q2 and 31% in H1, driven by DRDO, DPSU, and global OEM projects. The segment now anchors the company’s growth story, but margin expectations need to be calibrated.
- Margin reality check: Defense margin this quarter was 22%. Management was explicit: margins cannot improve because defense is increasingly competitive and most contracts go to bids. Only OEM engagement offers margin upside, and even then, management “would not commit to anything more than 22%.” The 22% level was described as “pretty high” and something they would be “lucky to maintain for next four years.”
- Revenue mix ahead: Missiles are expected to contribute ~40% of future defense revenues, radars and antennas ~30–35%, unmanned systems as the third leg, and ground systems a very small portion.
- Execution timing shifted forward: Because the move to the new facility will cause disturbance (potentially losing two to three weeks), management forced extra work into Q2 and Q3. Q3 is expected to be as good as Q2. Q4 will be a “filler quarter” rather than an accelerated one, with just enough to fulfill the 45% growth commitment.
Dr. S. Ravinarayanan: “I do not think that margins of defense can improve, I do not believe anywhere because defense is getting very competitive, there is a lot of competition, most of them go on bids. And there is no way I think with Indian defense, we can increase the margin. Only way we can do this is OEM. OEM engagement can increase our margin. As you know, that we are working with three-pronged efforts and OEM, OEM, there is a margin possibility. But I would not commit to anything more than 22%. 22% is pretty high, as far as I am concerned, in my 40 years of my experience, it is pretty high and I would be lucky to maintain that for next four years.”
The Product Pipeline: Seekers, Counter-Drones & Test Benches
A series of discrete programs sit inside the defense growth story, each with its own timeline and conversion risk.
- BrahMos ESA seeker: The government has asked AXISCADES and one other company to develop a new ESA-based radar seeker to replace older Zimble-based technology. A successful trial is hoped for before March; if qualified, orders from ESA could begin as early as next year. Management declined to comment on order quantities.
- Counter-drone systems (hard-kill): An MoU with Cilas brings a laser-based hard-kill product tested in Ukraine and NATO. AXISCADES is designing the full system for integration with Indian armed forces, filling a gap where only jamming and soft-kill options exist today. The company has already received emergency procurement orders for man-portable counter-drone systems (both man-portable and hand-held versions) and is working on delivery. More trials are ongoing. The ambition is to capture 20–30% of this market and be among the top three players consistently.
- MBDA test benches: The decade-old relationship has expanded; AXISCADES is now part of MBDA’s global supply chain, handling all global requirements from India. Three benches will be completed this financial year, with five to ten delivered annually thereafter.
- TACAN antenna: Development is complete and approved by the customer. A production order is expected in two to three weeks, maximum one month.
- QRSAM: Around seven systems are expected in the next two months but will not contribute to FY26. Production orders are expected by March, but the FY27 contribution will be “very, very limited.” Management says there is a sufficient buffer in the pipeline to meet FY27 goals without it.
- LLTR: Awaiting negotiation with BEL; an order is expected by January.
Dr. S. Ravinarayanan: “Cilas is somewhat a very innovative hard-kill, laser-kill, which is by far the most superior product. It is tested in Ukraine war and NATO and other things. We were privileged to receive the technology and support and part of the whole thing. And we are designing the whole system to be integrated with Indian armed forces for handling the hard-kill. There is no proper hard-kill option available at this stage. We are doing jamming and soft-kill so far. Hard-kill using laser and energy weapons has never been… not in a big way in India. So, this would be very much needed.”
ESAI & Hyperscalers: A Deliberate Trough Before the Ramp
The ESAI segment slowed because the company is moving from a design-only model into manufacturing, setting up an EMS facility. The Aeroland facility is almost ready, equipment arrives in a month, and hyperscaler certifications are expected by March. No improvement is expected in Q3 or Q4 for ESAI; other segments will compensate.
- Hyperscaler-I: Currently a \$2 mn relationship, expected to jump to \$6–7 mn next year if the facility is ready.
- Hyperscaler-II: Currently ~\$0.5–1 mn, expected to double next year.
- Mistral EMS facility: Coming online by March ‘26, with \$8–10 mn of revenue expected in FY27.
- US operations note: Hyperscalers want every operation shifted to India, diluting interest in the US. Anchor customers (Texas Instruments, Qualcomm, two hyperscalers) are now mostly India-key. The company has only 34 H1 visa holders in the US out of ~120 people.
Dr. S. Ravinarayanan: “Hyperscaler-I will have an exponential growth next year. So, this year we are doing $2 million with them. Next year it will be around maybe $6 or $7 million next year, hopefully if the facility is ready.”
Non-Core Recalibration & the Divestment Timeline
The company is actively recalibrating non-core verticals to be margin-accretive, with positive margins already showing progress. A strategic advisor has been engaged to review the business portfolio, with results expected by the end of this quarter or Q4.
- Divestment timeline: The non-core divestment plan is “very much on track” and expected to conclude by this financial year, i.e., March. Management says it will generate sufficient cash but declined to disclose the expected value or one-time financial impact, saying the plan is “still on the drawing table.”
- Tax rate drag: The higher tax rate this quarter stems from ADD Solutions recording a loss, which draws down PAT. The full-year average tax rate is expected not to exceed 25–26%.
Aerospace Margins & the Export Thesis
- Aerospace margin dip is seasonal: Q2 margins compressed from Q1 because Q2 is typically a slow period due to the European summer break. Management expects a recovery from Q3 onward and says the year-on-year average will stay at about 18.5%-plus, with no decline.
- Export strategy is three-tiered: Over 60% of revenue will come from Indian-based programs and offset fulfillment. The second level is OEM engagement with cost-arbitrage work on older products. The third is own-product exports, especially in unmanned systems, which management calls “a great leveler” with significant export potential.
- R&D vs. foreign technology split: Overall, 50–60% of work is based on indigenous R&D, with 40% involving foreign technology on a build-to-print basis. Missiles for India are purely indigenous; for foreign business, technology is taken from abroad. Unmanned systems are purely indigenous but integrate best-of-breed solutions from around the world.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY26 core revenue growth | ~45% growth in core domains | FY26 (on track per H1) |
| FY26 EBITDA growth | ~45% growth in overall EBITDA | FY26 (on track per H1) |
| FY27 growth | Similar ~45% growth in core and EBITDA | FY27 |
| FY28–FY30 growth | 70% annual growth, driven by new facilities | FY28, FY29, FY30 |
| Power930 revenue target | ₹9,000 crores (~\$1 bn) | By 2030 |
| Per capita EBITDA improvement | 30% improvement | FY26 (on track in H1) |
| Devanahalli Atmanirbhar Phase I | Radar manufacturing, assembly, antenna complete | September next year |
| Devanahalli Atmanirbhar Phase II | Aerospace field shops, supply chain ready | December next year |
| Mistral EMS facility | Online, generating \$8–10 mn revenue | By March ‘26; revenue in FY27 |
| Non-core divestment | Concluded | By March (this financial year) |
| BrahMos ESA seeker qualification | Successful trial; orders from ESA begin | Trial before March; orders as early as next year |
| TACAN antenna production order | Received | Within two to three weeks, maximum one month |
| LLTR order | Received | By January |
| Strategic investment in SPV | Taken | Likely Q1 of next year |
| Strategic advisor portfolio review | Result known | End of this quarter or Q4 |
| Defense margin ceiling | Maintain at 22% (no commitment to exceed) | Next four years |
| Aerospace margin floor | Year-on-year average ~18.5%-plus, will not go down | Ongoing |
| Full-year tax rate | Not more than 25–26% | FY26 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Consolidated revenue | ₹299 crores, +13% YoY and +22.7% QoQ |
| H1 FY26 revenue | ₹543 crores, +11.2% YoY |
| EBITDA | ₹47 crores (all-time high), +41.5% YoY |
| EBITDA margin | 15.7%, expanded from prior year |
| Profit after tax | ₹23 crores, +89% YoY |
| H1 FY26 EBITDA | ₹81 crores, +25.7% YoY, margin 14.9% |
| H1 FY26 PAT | ₹44 crores, +51.6% YoY |
| H1 FY26 diluted EPS (non-annualized) | ₹10.21, +53% YoY |
| Core domains EBITDA margin (H1) | 19%, aerospace, defense, and ESAI contributed 75% of H1 revenue |
| Defense revenue growth | +37% YoY in Q2, +31% in H1 |
| Aerospace revenue growth | +16% YoY in Q2, +12% in H1 |
| Defense segment margin | 22%, management considers this high and aims to maintain it |
| Aerospace segment margin expectation | ~18.5% average for full year; Q2 compressed by European summer break |
| Consolidated net worth | ₹700 crores |
| Net debt | ~₹50 crores |
| Gross debt | ~₹163 crores |
| Phase-I CAPEX (current FY) | ₹150–180 crores, with spillover to FY27 |
| Total CAPEX plan (3 years, including Hyderabad) | ~₹1,500 crores across three phases |
| Full-year tax rate expectation | Not more than 25%–26% |
| ESOP cost (Q2) | ~₹2.5 crores |
| ESOP cost (full-year expected) | ₹15–20 crores |
| Hyperscaler-I revenue | \$2 million currently, expected \$6–7 million next year |
| Hyperscaler-II revenue | ~\$0.5–1 million currently, expected to double next year |
| MBDA test benches | 3 benches to be completed this FY; 5–10 benches per year thereafter |
| QRSAM systems expected | ~7 systems in next two months, contributing to FY27, not FY26 |
| Mistral EMS facility revenue expectation (FY27) | \$8–10 million, management confirmed possibility |
| Non-core divestment timeline | Expected to conclude by March FY26 |
| Devanahalli Atmanirbhar Complex Phase-I completion | Target September next year |
| LLTR order expectation | Expected by January |